The Promise of Genomics and the Development of Targeted Therapies for Cutaneous Squamous Cell Carcinoma

scientific article published on 18 June 2015

The Promise of Genomics and the Development of Targeted Therapies for Cutaneous Squamous Cell Carcinoma is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.2340/00015555-2181
P698PubMed publication ID26084328

P50authorGareth J InmanQ58673347
Catherine HarwoodQ62662925
P2093author name stringIrene M Leigh
Charlotte M Proby
P433issue1
P921main subjectgenomicsQ222046
P304page(s)3-16
P577publication date2015-06-18
P1433published inActa Dermato-VenereologicaQ18326503
P1476titleThe Promise of Genomics and the Development of Targeted Therapies for Cutaneous Squamous Cell Carcinoma
P478volume96

Reverse relations

cites work (P2860)
Q92128642A Unique Panel of Patient-Derived Cutaneous Squamous Cell Carcinoma Cell Lines Provides a Preclinical Pathway for Therapeutic Testing
Q55054189Cutaneous Papillomaviruses and Non-melanoma Skin Cancer: Causal Agents or Innocent Bystanders?
Q26745755Does Notch play a tumor suppressor role across diverse squamous cell carcinomas?
Q92149785Genome wide DNA methylation profiling identifies specific epigenetic features in high-risk cutaneous squamous cell carcinoma
Q64054812Immunotherapy in non-melanoma skin cancer: updates and new perspectives
Q99637911Matrix metalloproteinases in keratinocyte carcinomas
Q99241113Multidisciplinary management of locally advanced and metastatic cutaneous squamous cell carcinoma
Q64257470New Vision in Photoprotection and Photorepair
Q48204354Organ transplantation and cutaneous squamous cell carcinoma: progress, pitfalls and priorities in immunosuppression-associated keratinocyte carcinoma.
Q38684394Phosphoinositide 3-Kinase-Dependent Signalling Pathways in Cutaneous Squamous Cell Carcinomas.
Q55476988Preclinical comparison of proteasome and ubiquitin E1 enzyme inhibitors in cutaneous squamous cell carcinoma: the identification of mechanisms of differential sensitivity.
Q47600127Silencing of G0/G1 switch gene 2 in cutaneous squamous cell carcinoma.
Q55137359Targeting the spliceosome for cutaneous squamous cell carcinoma therapy: a role for c-MYC and wild-type p53 in determining the degree of tumour selectivity.
Q58756343The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature
Q46271884The pathogenesis of cutaneous squamous cell carcinoma in organ transplant recipients.

Search more.